Latest News

Latest News

News from the World Hepatitis Alliance

World Hepatitis Alliance’s ever-growing membership base

31 Jan 2015 Bridie Taylor

Central to the success of the World Hepatitis Alliance are our member groups around the world. To stimulate political interest in and action on...

Joining expert committees to promote harm reduction

31 Jan 2015 Bridie Taylor

Harm reduction policies are proven to save lives. Globally, as many as 67% of People Who Inject Drugs (PWIDs) have hepatitis C and an additional 8.4...

Promoting screening among high risk communities with new multi-lingual tool

31 Jan 2015 Bridie Taylor

In Europe, migrant populations are disproportionally affected by hepatitis B and C. Crucial to reducing the burden is improving screening among these...

Supporting the development of national action plans in South America

31 Jan 2015 Bridie Taylor

Government commitment to comprehensive national action plans is key to addressing the burden of viral hepatitis. To support the development of...

Exploring new treatment developments and innovative ways to finance healthcare

31 Jan 2015 Bridie Taylor

New therapeutic developments are revolutionising the way hepatitis is treated. But with a global lack of funding, how can these pioneering new drugs...

Pages

News from infohep

Hepatitis C rates in US track the opioid epidemic

14 Dec 2018 Liz Highleyman
Nearly 2.4 million people in the United States are living with active hepatitis C virus (HCV) infection, according to the latest data from the US...

Burden of severe liver disease due to fatty liver will more than double by 2030

7 Dec 2018 Keith Alcorn
If current trends in obesity and diabetes continue, at least 520 million people will be living with non-alcoholic fatty liver disease in western...

Thyroid hormone receptor agonists reduce liver fat in people with NAFLD

29 Nov 2018 Liz Highleyman
Thyroid hormone activation appears to be a promising approach for treating fatty liver disease, according to a pair of studies presented at the AASLD...

Nivolumab works well for liver cancer patients with advanced disease

26 Nov 2018 Liz Highleyman
Nivolumab (Opdivo), a checkpoint inhibitor that helps the immune system fight cancer, was associated with tumour shrinkage or disease stabilisation...

Australian experience shows high DAA uptake and rapid fall in rates of HCV viraemia among people who inject drugs

26 Nov 2018 Michael Carter
Providing hepatitis C virus (HCV) therapy with direct-acting antivirals (DAAs) to people who inject drugs can achieve rapid reductions in community...

Recent incarceration increases HIV and hepatitis C risk for people who inject drugs

19 Nov 2018 Michael Carter
People who inject drugs (PWID) recently released from prison or jail have a substantially increased risk of acquiring infection with HIV or hepatitis...

People who inject drugs have a high hepatitis C cure rate despite imperfect adherence

15 Nov 2018 Liz Highleyman
Most people who inject drugs completed treatment with sofosbuvir/velpatasvir (Epclusa) and achieved sustained virological response (SVR) in a real-...

8 weeks of Maviret cures 98% of people with hepatitis C and cirrhosis

14 Nov 2018 Keith Alcorn
An 8-week course of the combination of glecaprevir and pibrentasvir (Maviret) is highly effective in curing hepatitis C in people with compensated...

Aspirin use associated with lower risk of liver cancer

13 Nov 2018 Liz Highleyman
Taking aspirin about twice a week for five years or more may reduce the risk of developing hepatocellular carcinoma (HCC) by about half, according to...

Sofosbuvir/ledipasvir cures most young children with hepatitis C

13 Nov 2018 Liz Highleyman
Almost all young children ages 3 to 6 years with chronic hepatitis C achieved sustained virological response after 12 weeks of treatment using...